Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Transaction in Own Shares

11th Feb 2013 07:28

SHIRE PLC - Transaction in Own Shares

SHIRE PLC - Transaction in Own Shares

PR Newswire

London, February 11

Transaction in Own Shares

February 11, 2013 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company"),announces that in accordance with the authority granted by shareholders at theCompany's Annual General Meeting on April 24, 2012 it purchased 21,050 of itsordinary shares of 5 pence each ("Ordinary Shares") on February 8, 2013 throughboth direct purchases of Ordinary Shares and through the purchase of OrdinaryShares underlying ADRs. The highest and lowest price paid for the directlyacquired Ordinary Shares was 2123.00 pence per share and 2104.00 pence pershare respectively and for those Ordinary Shares acquired through the purchaseof ADRs was 3345.00 cents per share and 3333.33 cents per share respectively.

The purchased shares will be held as treasury shares. Following the abovepurchase, the Company holds 4,759,774 Ordinary Shares as treasury shares andhas 557,799,700 Ordinary Shares in issue (excluding treasury shares).

The purchases were made by an independent third party which makes its tradingdecisions independently of, and uninfluenced by the Company. The independenceof the third party enables the Company to continue to purchase Ordinary Shares(including Ordinary Shares underlying ADRs) during close periods and otherprohibited periods, should they arise. The third party has been appointed bythe Company to make purchases to December 31, 2013.

For further information please contact:

Investor RelationsEric Rojas [email protected] +1 781 482 0999Sarah Elton-Farr [email protected] +44 1256 894157Notes to editors

Shire enables people with life-altering conditions to lead better lives.

Through our deep understanding of patients' needs, we develop and providehealthcare in the areas of:

* Behavioral Health and Gastro Intestinal conditions * Rare Diseases * Regenerative Medicine

as well as other symptomatic conditions treated by specialist physicians.

We aspire to imagine and lead the future of healthcare, creating value forpatients, physicians, policymakers, payors and our shareholders.

Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PXPress Release

www.shire.com


Related Shares:

Shire
FTSE 100 Latest
Value8,774.65
Change-17.15